NIH researchers are up-front about their support from drug companies, right? Wrong!

Thursday, April 01, 2010 by: S. L. Baker, features writer
Tags: medical research, corruption, health news

eTrust Pro Certified

Most Viewed Articles
Popular on Facebook
BACK INTO THE CLOSET: Why U.S. reporters are not allowed to write about rainbow events in nations where being gay is still condemned
Depopulation test run? 75% of children who received vaccines in Mexican town now dead or hospitalized
INVESTIGATION: Three days before Dr. Bradstreet was found dead in a river, U.S. govt. agents raided his research facility to seize a breakthrough cancer treatment called GcMAF
A family destroyed: Six-month-old dies after clinic injects baby with 13 vaccines at once without mother's informed consent
BOMBSHELL: China and America already at war: Tianjin explosion carried out by Pentagon space weapon in retaliation for Yuan currency devaluation... Military helicopters now patrolling Beijing
Companies begin planting microchips under employees' skin
BAM! Chipotle goes 100% non-GMO; flatly rejecting the biotech industry and its toxic food ingredients
ECONOMIC SLAVERY FOR ALL: While we were distracted with the Confederate flag flap, Congress quietly forfeited our entire economic future via fast-track trade authority
McDonald's in global profit free fall as people everywhere increasingly reject chemically-altered toxic fast food
March Against Monsanto explodes globally... World citizens stage massive protests across 38 countries, 428 cities... mainstream media pretends it never happened
SCOTUS same-sex marriage decision may have just legalized the concealed carry of loaded firearms across all 50 states, nullifying gun laws everywhere
Vicious attack on Dr. Oz actually waged by biotech mafia; plot to destroy Oz launched after episode on glyphosate toxicity went viral
Nearly every mass shooting in the last 20 years shares one surprising thing? and it's not guns
Holistic cancer treatment pioneer Dr. Nicholas Gonzalez dies suddenly; patients mourn the loss of a compassionate, innovative doctor who helped thousands heal from cancer
Wild eyes and bowl cuts: Why do mass shooters always share the same hair styles and crazed zombie stares?
Genetically white woman now claims self-identify as black: If you can choose your gender, can you also choose your race? What about your species? Can a human claim to be a llama?
Mind control through emotional domination: How we're all being manipulated by the "crisis of the NOW"
Costco stops selling antibiotic laden chicken in response to consumer demand
(NaturalNews) Medical research that is sponsored by drug companies has long been a conundrum. After all, scientists often welcome the big bucks of the drug industry in order to finance their studies -- but can they be totally objective when they are supported by Big Pharma? NaturalNews has previously covered this problem and how mainstream medicine, including the Journal of the American Medical Association (JAMA), has glossed over issues of researchers failing to disclose their association with drug companies (http://www.naturalnews.com/019914_JAMA_medic...).

But at least the U.S. government's own National Institutes of Health (NIH) funded scientists are open about their financial arrangements with drug companies, right? Wrong. And the Project On Government Oversight (POGO), an independent nonprofit group that investigates and exposes corruption and other misconduct in the federal government, is calling the NIH out on this problem.

POGO has gone public to urge NIH Director Francis Collins to deal strongly and openly with financial conflicts of interest among researchers funded by the NIH in universities and medical schools. Currently, the financial arrangements are reported on a strictly confidential basis only to the researchers' institutions. This secrecy has obviously created opportunities for abuses and conflicts of interest involving scientists funded by Big Pharma.

In a letter sent to Dr. Collins on March 11, POGO demanded that NIH sponsored scientists' financial arrangements be made easily accessible to not only members of the U.S. Congress and journalists but to anyone in the public who wants this information. For example, POGO suggested that the information be made available in a public database posted on a website.

"This kind of public disclosure is one of the best ways to protect against financial conflicts of interest in medical research," POGO Executive Director Danielle Brian said in a press statement.

In a published interview six months ago, Dr. Collins claimed he supported the public release of NIH researchers' financial backing. "I personally am in favor of the idea that sunshine is the best disinfectant. The idea of having a public database where all investigators disclose what kinds of financial arrangement they have with outside organization is a good thing," he stated. However, a move toward public access of this information remains, so far, all talk and no action.

Meanwhile, yet another worrisome all-too-cozy relationship between Big Pharma and scientists has just been revealed by Mayo Clinic research published by the British Medical Journal.

It turns out that virtually all researchers who came up with positive results for the anti-diabetic drug rosiglitazone had financial relationships with pharmaceutical companies.

In 2007, a large scale review of rosiglitazone concluded the drug wasn't the safe medication it was hyped to be. In fact, taking the drug caused a significant increase in heart attack risk. So Mayo researchers decided to assess over 200 articles on rosiglitazone to see if they spotted any possible links between authors' financial conflicts of interest and the scientists' contentions the drug was safe and effective.

The results showed about half of the study authors (45%) had financial conflicts of interest and almost a fourth did not disclose this information. The authors of three studies included in the latter group apparently downright lied -- they published a statement declaring they had no conflict of interest.

Most telling was the bottom line: almost all, 94% of researchers who reported glowing results on the safety of rosiglitazone were more likely to have a financial conflict of interest with a Big Pharma company than were researchers who reached negative views about the drug.

For more information:

Follow real-time breaking news headlines on
Medical research at FETCH.news
Join over four million monthly readers. Your privacy is protected. Unsubscribe at any time.
comments powered by Disqus
Take Action: Support NaturalNews.com by linking back to this article from your website

Permalink to this article:

Embed article link: (copy HTML code below):

Reprinting this article:
Non-commercial use OK, cite NaturalNews.com with clickable link.

Follow Natural News on Facebook, Twitter, Google Plus, and Pinterest

Colloidal Silver

Advertise with NaturalNews...

Support NaturalNews Sponsors:

Advertise with NaturalNews...


Sign up for the FREE Natural News Email Newsletter

Receive breaking news on GMOs, vaccines, fluoride, radiation protection, natural cures, food safety alerts and interviews with the world's top experts on natural health and more.

Join over 7 million monthly readers of NaturalNews.com, the internet's No. 1 natural health news site. (Source: Alexa.com)

Your email address *

Please enter the code you see above*

No Thanks

Already have it and love it!

Natural News supports and helps fund these organizations:

* Required. Once you click submit, we will send you an email asking you to confirm your free registration. Your privacy is assured and your information is kept confidential. You may unsubscribe at anytime.